Michal Segal

868 citations
16 papers · 327 indexed · h-index 9
Topics
Colorectal Cancer Treatments and Studies (4 papers)Neuroendocrine Tumor Research Advances (3 papers)Neuroblastoma Research and Treatments (3 papers)

In The Last Decade

Michal Segal

16 papers receiving 314 citations

Peers

Michal Segal
Comparison fields: 5 of 61
  • Oncology 219
  • Molecular Biology 71
  • Pulmonary and Respiratory Medicine 56
  • Cancer Research 55
  • Epidemiology 47
Replace Gwen Wark with:
Gwen Wark United Kingdom
Delano M. Pfeifle United States
Hirofumi Rokutan Japan
Riccardo Lobefaro Italy
Jennifer H. Benbow United States
Carys Morgan United Kingdom
M Izuo Japan
Christian Focan Belgium
Marion Kuper‐Hommel New Zealand
Delia De Lisi Italy
Michal Segal relative to Gwen Wark United Kingdom Gwen Wark's profile →
Citations per field
00.5×4.7×
Gwen Wark · 1×
Citations per year

Countries citing papers authored by Michal Segal

Since Specialization
Citations

This map shows the geographic impact of Michal Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Segal more than expected).

Fields of papers citing papers by Michal Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Segal. The network helps show where Michal Segal may publish in the future.

Co-authorship network of co-authors of Michal Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Segal. A scholar is included among the top collaborators of Michal Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Segal. Michal Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 1
3 44
4 15
5 30
6 7
7 2
8 56
9 3
10 4
11 9
12 46
13
[Testicular metastasis from transitional cell carcinoma of the bladder].
2
14 32
15 56
16 18

About Michal Segal

Michal Segal is a scholar working on Oncology, Cancer Research and Neurology, having authored 16 papers that have together received 327 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Oncology (219 citations), Cancer Research (55 citations) and Gastroenterology (16 citations). Michal Segal has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Leslie R. Laufman, Ralph W. Roach, Marinela Capanu, Ellen Hollywood, Leonard B. Saltz, Laura H. Tang, David B. Solit, M. Catherine Pietanza, Diane Reidy‐Lagunes and Andrew D. Cohen. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026